Name | Aliskiren fumarate |
---|
Description | Aliskiren fumarate is an orally active, highly potent and selective renin inhibitor, with IC50 of 1.5 nM. Aliskiren fumarate can be used for the research of hypertension, cardiovascular diseases and cancer cachexia[1][2][3]. |
---|---|
Related Catalog | |
Target |
IC50: 1.5 nM (renin)[1] |
In Vivo | Aliskiren fumarate (< 10 mg/kg, Orally, daily) inhibits plasma renin activity and lowers blood pressure in sodium-depleted marmosets[2]. Aliskiren fumarate (10 mg/kg, Intragastrically, once) significantly alleviates multiple cachexia‑associated symptoms in BALB/c mice bearing C26 mouse colon carcinoma cells, including BW loss, tumor burden, muscle wasting, muscular dysfunction, and shortened survival[3]. |
References |
Molecular Formula | C34H57N3O10 |
---|---|
Molecular Weight | 667.83 |